Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Cho‐Hung Chiang"'
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, Yuan Ping Hsia, Yu-Cheng Chang, Xin Ya See, Tsu Hsien Wang, Juien Lo, Weitao Liu, Cheryn Yu Wei Choo, Yu-Che Lee, Kevin Sheng Kai Ma
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Objectives Randomised controlled trials (RCTs) have demonstrated conflicting results regarding the effects of corticosteroids on the treatment of severe community-acquired pneumonia (CAP). We aimed to investigate the efficacy and safety of different
Externí odkaz:
https://doaj.org/article/5b1457ba7fb44f39bbfd0de33dddcf9b
Autor:
Cho-Han Chiang, Xin Ya See, Tsu Hsien Wang, Yu-Cheng Chang, Jui-En Lo, Wei-Tao Liu, Cheryn Yu Wei Choo, Cho-Hsien Chiang, Yuan Ping Hsia, Cho-Hung Chiang
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-3 (2023)
Externí odkaz:
https://doaj.org/article/ec4b47357e6148cdbdac1e27e35d8733
Autor:
Cho‐Han Chiang, Yu‐Cheng Chang, Shih‐Syuan Wang, Yuan‐Jen Chen, Xin Ya See, Chun‐Yu Peng, Yuan Ping Hsia, Cho‐Hsien Chiang, Cho‐Hung Chiang, Cheng‐Ming Peng
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 9583-9588 (2023)
Abstract Background Certain angiotensin receptor blockers (ARBs) have peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) activation property, which has been associated with improved programmed cell death ligand 1 blockade and cytotoxic T l
Externí odkaz:
https://doaj.org/article/899860dbd8674a6fb8079d77723d06b4
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 8, Pp 1962-1962 (2020)
Externí odkaz:
https://doaj.org/article/95703c78492146b887c4c2a385975a4b
Autor:
Chun-Yu Peng, Yu-Cheng Chang, Changlin Gong, Yu Chang, Kuan-Yu Chi, Chieh-Lien Hsiao, Cho-Hung Chiang, Cho-Han Chiang
Publikováno v:
Anesthesiology; Nov2024, Vol. 141 Issue 5, p1009-1012, 4p
Autor:
Cho-Han Chiang, Yuan-Jen Chen, Cho-Hsien Chiang, Cheng-Ying Chen, Yu-Cheng Chang, Shih-Syuan Wang, Xin Ya See, Chuan-Sheng Horng, Chun-Yu Peng, Yuan Ping Hsia, Cheng-Ming Peng, Cho-Hung Chiang
Publikováno v:
Cancer Immunology, Immunotherapy. 72:1951-1956
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c35cb6ba7f58cd97395b7351c4f66c51
https://doi.org/10.1007/s00262-022-03363-6
https://doi.org/10.1007/s00262-022-03363-6
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Kevin Sheng-Kai Ma, Yuan Ping Hsia, Yu-wen Lee, Han-Ru Wu, Cho-Hsien Chiang, Chun-Yu Peng, James Cheng-Chung Wei, Her-Shyong Shiah, Cheng-Ming Peng, Tomas G Neilan
Publikováno v:
Japanese Journal of Clinical Oncology. 52:1389-1398
Objectives Immune checkpoint inhibitors are associated with adverse cardiovascular events. However, there are no data characterizing cardiovascular events among Asians on immune checkpoint inhibitors. We aim to determine the incidence and risk of car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16841869f40b8438b22f02c9ae266073
https://doi.org/10.1093/jjco/hyac150
https://doi.org/10.1093/jjco/hyac150
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, Kevin Sheng-Kai Ma, Chun-Yu Peng, Yuan Ping Hsia, Chuan-Sheng Horng, Cheng-Ying Chen, Yu-Cheng Chang, Xin Ya See, Yuan-Jen Chen, Shih-Syuan Wang, Giselle A Suero-Abreu, LR Peterson, Paaladinesh Thavendiranathan, Philippe Armand, Cheng-Ming Peng, Her-Shyong Shiah, Tomas G Neilan
Publikováno v:
Heart
ObjectivesSodium-glucose cotransporter-2 inhibitors (SGLT2i) reduce heart failure (HF) in at-risk patients and may possess antitumour effects. We examined the effect of SGLT2i on HF and mortality among patients with cancer and diabetes.MethodsThis wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad28687ea28a167810df6ddcf36a018
https://europepmc.org/articles/PMC10037540/
https://europepmc.org/articles/PMC10037540/
Autor:
Cho-Han Chiang, Cho-Hung Chiang, Cho-Hsien Chiang, Jing-Huey Chiu, Kevin Sheng-Kai Ma, Brian Shiian Chen, Yu-Ze Luan, Teng-Chieh Cheng, Ching-Lung Hsieh, Cheng-Ming Peng
Publikováno v:
Pancreas. 51:e107-e109
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34c292df2807df6537092bc4f406f636
https://doi.org/10.1097/mpa.0000000000002125
https://doi.org/10.1097/mpa.0000000000002125
Autor:
Stefan Blankenberg, Pui-Un Tang, Tomas G. Neilan, Gin Hoong Lee, William F. Peacock, Raphael Twerenbold, Nicolas Buttinger, Michael A. Liu, Christian Mueller, Evangelos Giannitsis, Arash Mokhtari, Wan-Ting Hsu, Martin Than, Michael Amann, Dirk Westermann, Johannes T Neumann, Dan Atar, Chien-Chang Lee, Kenji Inoue, Richard M. Nowak, K.W. Su, Ulf Ekelund, Tonje R. Johannessen, Derek P. Chew, Philipp Bahrmann, Francisco Ojeda, John W. Pickering, Cho-Han Chiang, Kiril M. Stoyanov, Andrew Worster, Christopher DeFilippi, Peter A. Kavsak, Cho-Hung Chiang, Nils A Sörensen, Onlak Ruangsomboon, Kevin Sheng-Kai Ma, Maureen Dooley, Willibald Hochholzer
Publikováno v:
Annals of Internal Medicine. 175:101-113
BACKGROUND The 2020 European Society of Cardiology (ESC) guidelines recommend using the 0/1-hour and 0/2-hour algorithms over the 0/3-hour algorithm as the first and second choices of high-sensitivity cardiac troponin (hs-cTn)-based strategies for tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8743ebcc81b7ec844880d46e99f3dfbc
https://doi.org/10.7326/m21-1499
https://doi.org/10.7326/m21-1499